Latest Schedule 13G passive stakes

Masahide Shigeno reports beneficial ownership of 5,451,420 ordinary shares, representing 9.1% of Micware Co., Ltd.

Kenji Narushima reports beneficial ownership of 12.2% of Micware Co., Ltd. ordinary shares, including shares issuable upon stock option exercise.

Unleash Immuno Oncolytics, Inc. has filed a Schedule 13G, reporting beneficial ownership of 300,000 shares, representing 9.94% of the outstanding common stock of TransCode Therapeutics, Inc.

Elena Rosa Braci has filed a Schedule 13G, reporting beneficial ownership of 186,236 shares, representing 6.17% of TransCode Therapeutics, Inc.'s common stock.

Daniel Eduardo Katzman has reported beneficial ownership of 155,611 shares, representing 5.16% of the outstanding common stock of TransCode Therapeutics, Inc.

Divisadero Street Capital Management, LP and affiliated entities have reported beneficial ownership of 5.8% of MediaAlpha, Inc.'s Class A Common Stock.

Sculptor Capital LP and its affiliates have disclosed beneficial ownership of 625,000 ordinary shares, representing 5.32% of the class, in Southern Cross Acquisition I Corp.

Sio Capital Management, LLC has reported a 3.15% ownership stake in Adagio Medical Holdings, Inc. as of June 30, 2026.

Sio Capital Management, LLC has reported a beneficial ownership of 4.94% in PMV Pharmaceuticals, Inc. as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.6% of Everspin Technologies Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.5% in GeneDx Holdings Corp. Class A Stock, as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.5% in GeneDx Holdings Corp. Class A Stock, as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 6.0% in JFrog Ltd., holding over 7.3 million shares.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 26,229,501 shares, representing 16.2% of DXC Technology Co.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 6.3% of Eagle Financial Services Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.7% in EyePoint Pharmaceuticals, Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.3% of FIGS, Inc. Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.9% of First Advantage Corp's common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.6% of First National Corp's common stock as of June 30, 2026.

BlackRock, Inc. has disclosed a beneficial ownership stake of 5.9% in First United Corp, holding 378,880 shares.

BlackRock, Inc. has reported beneficial ownership of 6.2% of Fossil Group Inc.'s common stock as of June 30, 2026, holding over 3.6 million shares.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 1.3% of Franklin Street Properties Corp. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.1% of Damora Therapeutics Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 5.9% of Hallador Energy Co.'s common stock as of June 30, 2026.

BlackRock, Inc. has updated its Schedule 13G filing, disclosing beneficial ownership of 1.5% of Health Catalyst, Inc.'s common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.1% in Hycroft Mining Holding Corp. common stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 5.5% in Hyperfine Inc.'s Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported a beneficial ownership of 7.3% in Hyperliquid Strategies Inc. common stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.7% of Immuneering Corp's Class A Stock as of June 30, 2026.

BlackRock, Inc. has reported beneficial ownership of 6.4% of InfuSystem Holdings, Inc. common stock as of June 30, 2026.